ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,736Medicare Part D Prescriptions Filled, Including Refills

Rank: 104 out of 939

$849K Total Retail Price of All Prescriptions

Rank: 74 out of 939

505 Patients Receiving at Least One Drug in Part D
61%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 505 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

23% of this provider’s 505 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 9,923 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
HYDROCODONE-ACETAMINOPHEN 691 288 S3 1 1
LISINOPRIL 642 364 2 3
SIMVASTATIN 528 317 3 2
AMLODIPINE BESYLATE 426 350 4 6
HYDROCHLOROTHIAZIDE 407 279 5 12
FUROSEMIDE 397 277 6 7
NEXIUM 377 198 7 18
POTASSIUM CHLORIDE 375 288 8 9
OMEPRAZOLE 375 223 8 5
LEVOTHYROXINE SODIUM 341 230 10 4
SERTRALINE HCL 309 231 11 24
TRAMADOL HCL 273 152 12 16
METOPROLOL TARTRATE 272 211 13 10
WARFARIN SODIUM 260 207 14 17
METFORMIN HCL 228 115 15 8
ZOLPIDEM TARTRATE 228 116 15 20
METOPROLOL SUCCINATE 228 170 15 21
MELOXICAM 213 92 18 14
PREDNISONE 197 132 19 42
TRAZODONE HCL 188 110 20 26
PROAIR HFA 176 89 21 41
CYCLOBENZAPRINE HCL 168 46 R 22 36
ATENOLOL 160 93 23 19
POLYETHYLENE GLYCOL 3350 160 129 23 57
CITALOPRAM HBR 143 33 25 15
ATORVASTATIN CALCIUM 124 81 26 22
ADVAIR DISKUS 120 89 27 60
GABAPENTIN 118 55 28 11
SULFAMETHOXAZOLE-TRIMETHOPRIM 113 82 29 64
GLYBURIDE 112 76 R 30 89
PROMETHAZINE HCL 110 49 R 31 68
TAMSULOSIN HCL 110 65 31 27
LOVASTATIN 106 63 33 46
AMOXICILLIN 106 72 33 92
CLOPIDOGREL 106 87 33 28
LYRICA 102 51 36 63
RANITIDINE HCL 101 67 37 35
DONEPEZIL HCL 101 101 37 30
ESCITALOPRAM OXALATE 100 51 39 61
ALLOPURINOL 99 77 40 31
AZITHROMYCIN 95 65 41 32
GLIPIZIDE 94 39 42 52
LANTUS 93 72 43 59
CARBIDOPA-LEVODOPA 85 49 44 102
BACLOFEN 85 50 44 157
CYMBALTA 84 60 46 44
VERAPAMIL ER 82 47 47 85
PLAVIX 81 67 48 48
VENLAFAXINE HCL ER 80 36 49 121
DIGOXIN 79 68 50 45
LOSARTAN-HYDROCHLOROTHIAZIDE 78 62 51 55
SPIRIVA 78 52 51 73
XOPENEX HFA 77 73 53 245
AMOX TR-POTASSIUM CLAVULANATE 75 57 54 144
ALENDRONATE SODIUM 74 72 55 40
LOSARTAN POTASSIUM 74 70 55 29
FAMOTIDINE 74 38 55 62
DIOVAN 73 61 58 50
AMLODIPINE BESYLATE-BENAZEPRIL 69 58 59 58
AMITRIPTYLINE HCL 69 55 R 59 38
DEXILANT 68 67 61 212
CARISOPRODOL 68 0 R 61 51
OXYBUTYNIN CHLORIDE 67 23 63 125
VENTOLIN HFA 66 21 64 80
CRESTOR 66 34 64 34
SPIRONOLACTONE 65 48 66 71
PANTOPRAZOLE SODIUM 61 28 67 66
SUCRALFATE 59 40 68 96
FENTANYL 59 43 S2 68 104
GEMFIBROZIL 59 40 68 100
NYSTATIN-TRIAMCINOLONE 58 52 71 314
LISINOPRIL-HYDROCHLOROTHIAZIDE 57 41 72 23
GLIPIZIDE XL 57 57 72 147
SINGULAIR 57 41 72 101
RAMIPRIL 56 30 75 91
PAROXETINE HCL 56 36 75 70
CIPROFLOXACIN HCL 55 50 77 54
ISOSORBIDE MONONITRATE ER 54 28 78 53
CELEBREX 54 44 78 106
DIVALPROEX SODIUM 52 26 80 95
INSULIN SYRINGE 50 37 81 97
LANTUS SOLOSTAR 50 27 81 128
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 6, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.